Biallelic variants in TBC1D24, which encodes a protein that regulates vesicular transport, are frequently identified in patients with DOORS (deafness, onychodystrophy, osteodystrophy, intellectual disability [previously referred to as mental retardation], and seizures) syndrome. The aim of the study was to identify a genetic cause in families with DOORS syndrome and without a TBC1D24 variant.
Exome or Sanger sequencing was performed in individuals with a clinical diagnosis of DOORS syndrome without TBC1D24 variants.
We identified the same truncating variant in ATP6V1B2 (NM_001693.4:c.1516C>T; p.Arg506*) in nine individuals from eight unrelated families with DOORS syndrome. This variant was already reported in individuals with dominant deafness onychodystrophy (DDOD) syndrome. Deafness was present in all individuals, along with onychodystrophy and abnormal fingers and/or toes. All families but one had developmental delay or intellectual disability and five individuals had epilepsy. We also describe two additional families with DDOD syndrome in whom the same variant was found.
We expand the phenotype associated with ATP6V1B2 and propose another causal gene for DOORS syndrome. This finding suggests that DDOD and DOORS syndromes might lie on a spectrum of clinically and molecularly related conditions.
Subscribe to Journal
Get full journal access for 1 year
only $41.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Campeau PM, Kasperaviciute D, Lu JT, et al. The genetic basis of DOORS syndrome: an exome-sequencing study. Lancet Neurol. 2014;13:44–58.
Yuan Y, Zhang J, Chang Q, et al. De novo mutation in ATP6V1B2 impairs lysosome acidification and causes dominant deafness-onychodystrophy syndrome. Cell Res. 2014;24:1370–1373.
Menendez I, Carranza C, Herrera M, et al. Dominant deafness-onychodystrophy syndrome caused by an ATP6V1B2 mutation. Clin Case Rep. 2017;5:376–379.
Kortum F, Caputo V, Bauer CK, et al. Mutations in KCNH1 and ATP6V1B2 cause Zimmermann–Laband syndrome. Nat Genet. 2015;47:661–667.
Popp B, Ekici AB, Thiel CT, et al. Exome Pool-Seq in neurodevelopmental disorders. Eur J Hum Genet. 2017;25:1364–1376.
Shaw M, Winczewska-Wiktor A, Badura-Stronka M, et al. EXOME REPORT: novel mutation in ATP6V1B2 segregating with autosomal dominant epilepsy, intellectual disability and mild gingival and nail abnormalities. Eur J Med Genet. 2020;63:103799.
Vind-Kezunovic D, Torring PM. A Danish family with dominant deafness-onychodystrophy syndrome. J Dermatol Case Rep. 2013;7:125–128.
White SM, Fahey M. Report of a further family with dominant deafness-onychodystrophy (DDOD) syndrome. Am J Med Genet A. 2011;155:2512–2515.
Murakami Y, Nguyen TTM, Baratang N, et al. Mutations in PIGB cause an inherited GPI biosynthesis defect with an axonal neuropathy and metabolic abnormality in severe cases. Am J Hum Genet. 2019;105:384–394.
Bauer CK, Schneeberger PE, Kortum F, et al. Gain-of-function mutations in KCNN3 encoding the small-conductance Ca(2+)-activated K(+) channel SK3 cause Zimmermann–Laband syndrome. Am J Hum Genet. 2019;104:1139–1157.
Kariminejad A, Ajeawung NF, Bozorgmehr B, et al. Kaufman oculo-cerebro-facial syndrome in a child with small and absent terminal phalanges and absent nails. J Hum Genet. 2017;62:465–471.
Campeau PM, Hennekam RC, group Dsc. DOORS syndrome: phenotype, genotype and comparison with Coffin–Siris syndrome. Am J Med Genet C Semin Med Genet. 2014;166C:327–332.
Mucha BE, Hennekam RCM, Sisodiya S, Campeau PM. TBC1D24-related disorders. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews. Seattle, WA: University of Washington; 1993.
Robinson GC, Miller JR, Bensimon JR. Familial ectodermal dysplasia with sensori-neural deafness and other anomalies. Pediatrics. 1962;30:797–802.
Kondoh T, Tsuru A, Matsumoto T, Matsuzaka T, Tsuji Y. Autosomal dominant onychodystrophy and congenital sensorineural deafness. J Hum Genet. 1999;44:60–62.
James AW, Miranda SG, Culver K, Hall BD, Golabi M. DOOR syndrome: clinical report, literature review and discussion of natural history. Am J Med Genet A. 2007;143A:2821–2831.
Finelli MJ, Aprile D, Castroflorio E, et al. The epilepsy-associated protein TBC1D24 is required for normal development, survival and vesicle trafficking in mammalian neurons. Hum Mol Genet. 2019;28:584–597.
Fernandes AC, Uytterhoeven V, Kuenen S, et al. Reduced synaptic vesicle protein degradation at lysosomes curbs TBC1D24/sky-induced neurodegeneration. J Cell Biol. 2014;207:453–462.
Uytterhoeven V, Kuenen S, Kasprowicz J, Miskiewicz K, Verstreken P. Loss of Skywalker reveals synaptic endosomes as sorting stations for synaptic vesicle proteins. Cell. 2011;145:117–132.
Fischer B, Lüthy K, Paesmans J, et al. Skywalker-TBC1D24 has a lipid-binding pocket mutated in epilepsy and required for synaptic function. Nat Struct Mol Biol. 2016;23:965–973.
Luthy K, Mei D, Fischer B, et al. TBC1D24-TLDc-related epilepsy exercise-induced dystonia: rescue by antioxidants in a disease model. Brain. 2019;142:2319–2335.
Vavassori S, Mayer A. A new life for an old pump: V-ATPase and neurotransmitter release. J Cell Biol. 2014;205:7–9.
Bell S, Rousseau J, Peng H, et al. Mutations in ACTL6B cause neurodevelopmental deficits and epilepsy and lead to loss of dendrites in human neurons. Am J Hum Genet. 2019;104:815–834.
Zhao W, Gao X, Qiu S, et al. A subunit of V-ATPases, ATP6V1B2, underlies the pathology of intellectual disability. EBioMedicine. 2019;45:408–421.
Kimble JE, White JG. On the control of germ cell development in Caenorhabditis elegans. Dev Biol. 1981;81:208–219.
Merkulova M, Paunescu TG, Azroyan A, Marshansky V, Breton S, Brown D. Mapping the H(+) (V)-ATPase interactome: identification of proteins involved in trafficking, folding, assembly and phosphorylation. Sci Rep. 2015;5:14827.
Merkulova M, Paunescu TG, Nair AV, et al. Targeted deletion of the Ncoa7 gene results in incomplete distal renal tubular acidosis in mice. Am J Physiol Renal Physiol. 2018;315:F173–F185.
Huttlin EL, Ting L, Bruckner RJ, et al. The BioPlex Network: a systematic exploration of the human interactome. Cell. 2015;162:425–440.
Doyle T, Moncorge O, Bonaventure B, et al. The interferon-inducible isoform of NCOA7 inhibits endosome-mediated viral entry. Nat Microbiol. 2018;3:1369–1376.
Marshansky V, Futai M. The V-type H+-ATPase in vesicular trafficking: targeting, regulation and function. Curr Opin Cell Biol. 2008;20:415–426.
Fassio A, Esposito A, Kato M, et al. De novo mutations of the ATP6V1A gene cause developmental encephalopathy with epilepsy. Brain. 2018;141:1703–1718.
Mucha BE, Banka S, Ajeawung NF, et al. A new microdeletion syndrome involving TBC1D24, ATP6V0C, and PDPK1 causes epilepsy, microcephaly, and developmental delay. Genet Med. 2019;21:1058–1064.
Van Damme T, Gardeitchik T, Mohamed M, et al. Mutations in ATP6V1E1 or ATP6V1A cause autosomal-recessive cutis laxa. Am J Hum Genet. 2017;100:216–227.
Abbas YM, Wu D, Bueler SA, Robinson CV, Rubinstein JL. Structure of V-ATPase from the mammalian brain. Science. 2020;367:1240–1246.
We thank all families. This study was funded in part by Canadian Institutes of Health Research and Fonds de la Recherche du Québec–Santé awards to P.M.C.
The authors declare no conflicts of interest.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Beauregard-Lacroix, E., Pacheco-Cuellar, G., Ajeawung, N.F. et al. DOORS syndrome and a recurrent truncating ATP6V1B2 variant. Genet Med (2020). https://doi.org/10.1038/s41436-020-00950-9
- DOORS syndrome
- DDOD syndrome
- ATP6V1B2 gene
- TBC1D24 gene
- exome sequencing